These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3421499)

  • 21. Thiacetarsamide in dogs: disposition kinetics and correlations with selected indocyanine green kinetic values.
    Holmes RA; Wilson RC; McCall JW
    Am J Vet Res; 1986 Jun; 47(6):1338-40. PubMed ID: 3729137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue distribution of bupivacaine enantiomers in sheep.
    Rutten AJ; Mather LE; McLean CF; Nancarrow C
    Chirality; 1993; 5(7):485-91. PubMed ID: 8240923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ropivacaine 0.25% compared with bupivacaine 0.25% by the caudal route.
    Da Conceicao MJ; Coelho L; Khalil M
    Paediatr Anaesth; 1999; 9(3):229-33. PubMed ID: 10320602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of vena caval banding in experimentally induced multiple portosystemic shunts in dogs.
    Butler-Howe LM; Boothe HW; Boothe DM; Laine GA; Calvin JA
    Am J Vet Res; 1993 Oct; 54(10):1774-83. PubMed ID: 8250407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antinociceptive and motor-blocking efficacy of ropivacaine and bupivacaine after epidural administration in the dog.
    Feldman HS; Dvoskin S; Arthur GR; Doucette AM
    Reg Anesth; 1996; 21(4):318-26. PubMed ID: 8837190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M; Wu WH; Look ZM; Silber BM; Yacobi A
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of bupivacaine after axillary brachial plexus block.
    Freysz M; Beal JL; D'Athis P; Mounie J; Wilkening M; Escousse A
    Int J Clin Pharmacol Ther Toxicol; 1987 Jul; 25(7):392-5. PubMed ID: 3623743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The in vivo blood, fat and muscle concentrations of lignocaine and bupivacaine in the hindquarters of sheep.
    Upton RN; Nancarrow C; McLean CF; Mather LE; Runciman WB
    Xenobiotica; 1991 Jan; 21(1):13-22. PubMed ID: 2003363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Threshold serum concentrations of bupivacaine associated with early CNS toxicity and pharmacokinetics of bupivacaine in young versus old rhesus monkeys.
    Veering BT; Denson DD; Burm AG; Sehlhorst CS; Spierdijk J
    Reg Anesth; 1989; 14(6):288-92. PubMed ID: 2486656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular effects and regional clearances of i.v. bupivacaine in sheep: enantiomeric analysis.
    Rutten AJ; Mather LE; McLean CF
    Br J Anaesth; 1991 Sep; 67(3):247-56. PubMed ID: 1911010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Displacement of lidocaine from the lung after bolus injection of bupivacaine.
    Ohmura S; Yamamoto K; Kobayashi T; Murakami S
    Can J Anaesth; 1993 Jul; 40(7):676-80. PubMed ID: 8403143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of the enantiomers of bupivacaine following intravenous administration of the racemate.
    Burm AG; van der Meer AD; van Kleef JW; Zeijlmans PW; Groen K
    Br J Clin Pharmacol; 1994 Aug; 38(2):125-9. PubMed ID: 7981012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of intravenous lipid emulsion on bupivacaine plasma concentration in humans.
    Litonius E; Tarkkila P; Neuvonen PJ; Rosenberg PH
    Anaesthesia; 2012 Jun; 67(6):600-5. PubMed ID: 22352703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of intravenous infusion of lidocaine on its pharmacokinetics in conscious instrumented dogs.
    Ngo LY; Tam YK; Tawfik S; Coutts RT; Gray MR
    J Pharm Sci; 1997 Aug; 86(8):944-52. PubMed ID: 9269873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of bupivacaine following caudal anesthesia in infants.
    Mazoit JX; Denson DD; Samii K
    Anesthesiology; 1988 Mar; 68(3):387-91. PubMed ID: 3344993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disposition of mepivacaine and bupivacaine enantiomers in sheep.
    Mather LE
    Br J Anaesth; 1991 Sep; 67(3):239-46. PubMed ID: 1911009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics of bupivacaine after clonidine pretreatment in mice.
    Bruguerolle B; Attolini L; Lorec AM; Gantenbein M
    Can J Anaesth; 1995 May; 42(5 Pt 1):434-7. PubMed ID: 7614654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infusion pharmacokinetics of Lipocurc™ (liposomal curcumin) and its metabolite tetrahydrocurcumin in Beagle dogs.
    Helson L; Bolger G; Majeed M; Vcelar B; Pucaj K; Matabudul D
    Anticancer Res; 2012 Oct; 32(10):4365-70. PubMed ID: 23060560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of interpleural bupivacaine in patients undergoing cholecystectomy.
    Mogg GA; Triggs EJ; Ismail Z; Higbie J; Frost M
    Br J Anaesth; 1990 Jun; 64(6):657-61. PubMed ID: 2378769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steady-state pharmacokinetics of interpleural bupivacaine in patients after cholecystectomy.
    Kastrissios H; Triggs EJ; Mogg GA; Sainsbury D; Higbie J; Leow K; Sidhu J
    Anaesth Intensive Care; 1990 May; 18(2):200-4. PubMed ID: 2368893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.